Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,676-1,700 of 2,022
CompletedNCT03688009

Mindfulness-Based Family Psychoeducation Intervention for Early Psychosis

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand what psychoeducation, a guided learning and support program, could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
China
Sponsor
The Hong Kong Polytechnic University
Condition
Schizophrenia
CompletedNCT05603260

Imagery Interventions for Auditory Vocal Hallucinations

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 65 Years
Countries
Netherlands
Sponsor
Hella Janssen
Condition
Schizophrenia
CompletedNCT03382639

A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Bulgaria, Czech Republic, Germany, Italy, Poland, Spain, Ukraine, United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
CompletedNCT03447548

Neurofeedback Training for High Risk Psychosis

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
Hartford Hospital
Condition
Schizophrenia
RecruitingNCT06278532

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

This study exists to see whether this type of care can make care clearer and more responsive. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Lithuania
Sponsor
Lithuanian University of Health Sciences
Condition
Schizophrenia
CompletedNCT03217357

tDCS, Stress and Risk for Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT02822092

Striatal Connectivity and Clinical Outcome in Psychosis

This study exists to see whether blood tests and biological markers can make care clearer and more responsive. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
TerminatedNCT05526833

An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 22 Years to 55 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
Not Yet RecruitingNCT05784961

Impact of tDCS on Cannabis Craving in Schizophrenia

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Centre hospitalier de Ville-Evrard, France
Condition
Schizophrenia
CompletedNCT04611737

Self-Determination Theory and Motivational Interviewing

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 20 Years to 80 Years
Countries
Taiwan
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Condition
Schizophrenia
TerminatedNCT04033978

Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
TerminatedNCT03608137

Cannabis and Thought Disorder in Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
CompletedNCT03101319

Role of Vitamin D Supplementation in Schizophrenia

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
India
Sponsor
Central Institute of Psychiatry, Ranchi, India
Condition
Schizophrenia
CompletedNCT00727103

Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 69 Years
Countries
United States
Sponsor
State University of New York - Upstate Medical University
Condition
Schizophrenia
CompletedNCT03048370

Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
RecruitingNCT05704582

RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Ciusss de L'Est de l'Île de Montréal
Condition
Schizophrenia
CompletedNCT00431574

Antipsychotic Medication Extended Dosing Study

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
CompletedNCT02576613

Modified Psychodynamic Psychotherapy for Patients With Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia
RecruitingNCT06127004

Metacognitive Training for Negative Symptoms

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
Sweden
Sponsor
Sormland County Council, Sweden
Condition
Schizophrenia
CompletedNCT04559529

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
CompletedNCT02022462

Project Bridge: Peer Health Navigator Intervention

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Southern California
Condition
Schizophrenia
Schizophrenia | Clinical Trials | HopeStage Research